Influence of demographic characteristics in the efficacy response of Parkinson’s disease patients with motor fluctuations: Post-hoc analysis from combined BIPARK-I and II
暂无分享,去创建一个
H. Reichmann | W. Poewe | A. Lees | J. Ferreira | N. Savić | F. Rocha | P. Soares-da-Silva | A. Santos | D. Magalhães | F. Ikedo
[1] Werner Poewe,et al. Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial , 2016, The Lancet Neurology.
[2] W. Poewe,et al. Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial , 2017, JAMA neurology.